Member Info for Blownitalready

https://www.bbc.co.uk/news/world-europe-53175459

Turnava: Frontera to stop the no-nonsense campaign, to sit at the negotiating table

After the government session, the Minister of Economy Natia Turnava talked to the American company " Frontera ". He said they had received all the information from the international arbitration they had about the company, so it would have the right to continue operating under the license it has.

The Minister of Economy states that the change of position is not connected with the meeting with the Ambassador of the United States of America to Georgia.

"We are ready for a very positive, substantive dialogue, which concerns the fact that the Frontera will be given the opportunity to continue its activities on the territory of Georgia, within the remaining licensed area that it has today. We are ready to talk about terms and conditions, especially considering that it employs about 190 people and their fate worries us. This requires the company Frontera to stop the nonsense campaign and sit down at the negotiating table. I urge the Front to sit down at the negotiating table, to talk about any issues that concern them and are of interest to them, "said Economy Minister Natia Turnava .

https://formulanews.ge/News/32136

American business faces incredible resistance from the Georgian government - Frontera

The American energy company " Frontera " will voice the accusations against the government once again at a special briefing. Frontera accuses the Georgian government of deliberately harassing American businesses in Georgia.

Expert Nodar Kharshiladze says relations with the United States are at their lowest level in 30 years. According to him, this fact will have a negative impact on the development of the country.

"Our purpose today is to start a new campaign, which refers to US-Russian relations. establishment of diplomatic relations until now there has never been such a low point, when practically every week our government sakritiko Letters from America, which is shameful for the country. There are many political reasons, but one of the main reasons is It is very unfortunate that the American business is oppressed in Georgia. It causes two problems - one is the political dimension, and our image is damaged, the other is the economic damage, "Kharshiladze said.

According to Zaza Mamulaishvili , President of Frontera , American companies face strong opposition from the Georgian government.

"Our company has been operating in Georgia for 23 years. We are the largest American investor in the country. We face incredible resistance from the Georgian government due to discriminatory treatment of us and American business in general. To be created, especially in the face of such a ruined economy, "he said.

https://formulanews.ge/News/32135

The director of the Frontera accuses Natia Turnava of blackmail and intimidation

The American energy company Frontera calls on the Georgian government to stop harassing their businesses and employees.

According to Zaza Mamulashvili, director of Frontera, American business in Georgia is being deliberately harassed when Russian companies are facing greenhouse conditions and tendering more. The company issued an official statement today. Zaza Mamulashvili says that the softened tone of the Minister of Economy is connected with the letters of the American Congressmen, the government is trying to deceive the international partners once again.

The Ministry of Economy expressed readiness to cooperate with Frontera two days ago, however, no one has contacted the company yet and the meeting has not been scheduled . The Ministry of Economy does not respond to the accusations of "Frontera" representation. Irakli Kobakhidze made a statement on behalf of the government.

The arbitration dispute with the company " Frontera " cost the state more than 30 million GEL, it demanded the termination of the contract with the state company, which was not satisfied by the arbitration . The dispute ended in April, with the parties not disclosing details. The opposition says the ministry has stepped back amid criticism from US congressmen.

Authorities have argued for the past year that the company would not compromise with Frontera . Tony's economy ministry changed after the US ambassador's visit to the agency. What did Kelly degnanma of the unknown, however, the ambassador was quoted as saying the press service of the Ministry of Economy departure times, the deputy minister and then minister issued statements. The Ministry of Economy has promised Frontera that it will create the conditions for continuing the work.

https://formulanews.ge/News/32085

After reading about the prime minister you can see why it really is an uphill struggle !

https://www.ceps.eu/georgia-has-another-new-prime-minister/

Update on COVID-19 Rapid Antigen Test Development Partnership with Cytiva



Positive initial data from first Affimer-based rapid test strips for SARS-COV-2 spike protein



Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents is pleased to announce that the first Affimer-based rapid test strips to detect SARS-COV-2 spike protein have been developed and evaluated by Avacta's partners at Cytiva (formerly GE Healthcare Life Sciences) and show positive initial performance data.



In mid-May Avacta provided Affimer reagents that are specific to the SARS-COV-2 spike protein to Cytiva which has now developed the first lateral flow test strips using these reagents and generated initial performance data using coronavirus spike protein.



These data show that the test strips detect the spike protein in model samples at concentrations within the clinical range found in saliva of patients with COVID-19. Work continues now to refine the test strip design, optimise its performance and get the best detection limit possible in order to generate the highest sensitivity in the final rapid test product.



Following the optimisation of the lateral flow test by Cytiva the design will then be transferred to manufacturing partners in the UK that are currently being put in place by Avacta. The Company is working with these manufacturers to compress the normal manufacturing, clinical validation and regulatory timelines in order to bring a product to market as quickly as possible.



Dr. Alastair Smith, Chief Executive of Avacta Group commented:



"I am delighted with the progress made by our partners at Cytiva and very encouraged by the positive data from the first test devices. We now need to optimise the test performance to achieve the best possible limit of detection as this will ultimately play a significant factor in determining the clinical sensitivity of the test.



This is a really positive step and we aim to have completed the optimisation very soon so that we can begin the transfer to manufacturers. I will be updating the market on progress in due course."



Klaus Hochleitner, Global Lead, Technology Product Specialist at Cytiva, commented:



"I am pleased that the test development has progressed from a working initial design to now focussing on optimising the test as much as possible. The Affimer reagents have worked well in lateral flow test strips and we are very encouraged by the initial data."



This announcement contains information which, prior to its disclosure, was considered inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 (MAR).



- Ends-

Check it out .....we will all be proud to wear it

https://tshirtprintinguk.co.uk/pages/tshirtprintingukcustomiser/tid-159294063595

I always wonder why investors need to tell us they are leaving or selling or buying !!

Great article to basically say that antibody tests are almost useless

https://www.dailymail.co.uk/health/article-8448393/Can-trust-antibody-test-expert-argues-theres-little-proof-work.html

apologies for the post guys....i had two screens up .
Also woant to say while i'm here.....thanks for the great finds in the last week or so. There is still a heartbeat ....

https://www.dailymail.co.uk/health/article-8448393/Can-trust-antibody-test-expert-argues-theres-little-proof-work.html

https://www.londonstockexchange.com/news-article/AVCT/update-on-affimer-r-therapy-for-covid-19-infection/14581972

Some info may have been missed off...please read here

Update on Affimer® Therapy for COVID-19 Infection
AVACTA GROUP PLC
Released 07:00:06 18 June 2020
RNS Number : 2969Q
Avacta Group PLC
18 June 2020





18 June 2020

Avacta Group plc

("Avacta" or "the Group" or "the Company")



Update on Affimer® Therapy for COVID-19 Infection



Infectivity assays carried out in collaboration with Glasgow University show that Affimer reagents prevent infection of human cells by a SARS-COV-2 model virus



Avacta Group plc (AIM: AVCT), the developer of Affimer biotherapeutics and reagents, is pleased to announce that collaborative work with the Centre for Virus Research at the University of Glasgow has shown that Affimer reagents which bind to the SARS-COV-2 virus spike protein prevent infection of human cells by a SARS-COV-2 model virus and therefore provide a potential therapy for COVID-19 infection.



Recently, Avacta reported that several of the Affimer reagents that had been generated to develop COVID-19 antigen tests inhibited the interaction between the coronavirus' spike protein and a receptor found on human cells, called ACE2, which the virus spike protein binds to as the first step in infecting cells.

Avacta has now successfully completed the initial phase of a collaboration with Professor David Bhella at the University of Glasgow showing that these "neutralising" Affimer reagents prevent a SARS-COV-2 model virus from entering human cells and therefore provide a potential therapy for COVID-19.



Affimer reagents have key benefits compared with antibodies as virus neutralising therapies: Their small size and high solubility means that a much higher concentration of Affimer molecules can be used in the drug formulation to more effectively block the spike proteins on each virus particle and better protect the patient; bispecific and trispecific Affimer neutralising therapies that bind to more than one part of the spike protein could ensure the effectiveness of the neutralising therapy even if the virus' spike protein mutates.



Work is continuing with Professor Bhella to further study the way in which the Affimer reagents prevent infection and Avacta is using this growing body of data actively to secure a large pharmaceutical partner to develop these potential therapeutic candidates rapidly.



Dr Alastair Smith, Chief Executive Officer of Avacta Group, commented:



"I am delighted that our collaborators at the University of Glasgow have confirmed that these Affimer reagents not only block the spike-ACE2 binding but efficiently prevent a SARS-COV-2 model virus from entering human cells. This is critical information that will help to establish a license deal with a large pharmaceutical partner that has the resources to carry out an accelerated clinical development programme.

Ivy - I was also all in on FRR.... thought I had done my homework on that too....
I obviously haven't learned....lol

Interesting views given about diversity .... I am utterly convinced that my research is going to improve my wealth considerably. So much so that I am "all in" on this company.
My take is most Aim companies are very poor Investments so the more of these you're invested in the greater degree/ chance of losing more money.
This is only my method and not endorsing it....
Good luck to everyone invested.

(CNN)Just as much of the US was improving, several states are going backward in the fight against the coronavirus with record-high daily case or hospitalization numbers.

Florida, Texas and Arizona have all set records for daily new cases this week. They're among 21 states across the country with increasing trends in new cases from one week to the next.

While some politicians have attributed higher case numbers to better testing, recent surges are outpacing the increase in tests, said Dr. Ezekiel Emanuel, chair of the Department of Medical Ethics and Health Policy at the University of Pennsylvania.
"You can have a small percentage increase because of testing in terms of number of cases," he said.
"But when you see 50% or 150% increase in the number of cases you are seeing -- which is what we are seeing across the South -- that's not testing. That's new cases. That's community spread."

https://edition.cnn.com/2020/06/17/health/us-coronavirus-wednesday/index.html

Part 2 -
It looks like today was a very big ‘shake’ to
move the price down while stock is simultaneously bought, taking the rest of the market short, including competing MM’s.

Something like this...

- Company broker appears to sell heavily.
- Market takes this as a signal of imminent bad news.
- Market spirals downward.
- Stock is mopped up at lower and lower levels.
- Buying, proportionate to the downward movement, does not print until after the close.
- The rest of the market cannot now rebalance ahead of what may appear tomorrow.

This pattern occurs prior to positive announcements, not negative updates.

If it were bad news brewing, you wouldn’t ordinarily see the after market Buy prints in such high volume, almost equal to the volume shares traded and printed within market hours. That’s a strong indicator.

Obviously this is all supposition and the clues are subject to interpretation.

Part 1-
Good evening all. Thought I would pop my head around the door.

It’s all getting rather interesting isn’t it.

Unusual to see prints still coming through +2 hours after the Close.

McNulty’s observations, while valid, represent sentiment and the effect of a significant PrimaryBid placing at the same price and timing of the institutions. Hence the volatility and the price not breaking higher on the news of the ‘transformational raise’.

They do not however, in my opinion, represent the underlying cause for the direction of travel.

As is often said on this Board, ‘nothing has changed’. If nothing has changed then there is typically equal buyers to sellers in a perfect market, which may experience volatility but rarely disproportionate intra-day price moves.

I would point to one or two ‘market mechanics’ as clues to understand what is happening.

1. The exceptionally high number of post-market prints of predominately Buy trades, while the SP has disproportionately moved down.

2. The MM of the company broker, appears to have been on the Offer consistently throughout today.

Now logic would have it, if the MM of the company broker had got wind there was imminent bad news, then clearly they would sell and clearly the other MM’s and the weak holders in the market would follow.

However, experience tells us, in such circumstances, the last thing a broker of the company would do is to signal to the entire market of a sell-off. This is just patently bad business, especially when you’ve just brought in a bunch of investors. Burn wealth management like that and suddenly you have no access to capital and you have no ‘sell-side’ broking business.

Also note. Institutions do not sell off in 10k parcels directly through the market. They have neither the time, the inclination or the compliance latitude. If they need out, they will place the entire block with either the broker of the company or their own broker (quite often their own broker...Compliance Officers don’t care about orderly markets, they care about TR1’s...of which there has been a lack of).

Most of the MM’s would not willingly move the SP below 120p when they are probably holding (or were) stock at that intrinsic value from the forward selling. MM’s will often take very cheap stock in such placing dynamics and they have up to 30 days to settle up their book. Plenty of time to see all the good news come out that the market has been waiting for and make a tidy profit.

So...if its improbable for the companies broker to violently and publicly sell and yet they are....and the number of undisclosed buys is disproportionately high.

To quote Sherlock Holmes; “When you have eliminated the impossible, whatever remains, however improbable, must be the truth?”

I suspect positive, not negative, news is imminent.

Duckduckgo browser .,... more control

Hants - you have summed up the situation perfectly.
Stay strong and keep long